91 related articles for article (PubMed ID: 28745321)
1. Conditional expression of Ki-Ras
Andò S; Malivindi R; Catalano S; Rizza P; Barone I; Panza S; Rovito D; Emprou C; Bornert JM; Laverny G; Metzger D
Oncogene; 2017 Nov; 36(46):6420-6431. PubMed ID: 28745321
[TBL] [Abstract][Full Text] [Related]
2. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
[TBL] [Abstract][Full Text] [Related]
3. Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ.
Frech MS; Halama ED; Tilli MT; Singh B; Gunther EJ; Chodosh LA; Flaws JA; Furth PA
Cancer Res; 2005 Feb; 65(3):681-5. PubMed ID: 15705859
[TBL] [Abstract][Full Text] [Related]
4. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.
Hoenerhoff MJ; Shibata MA; Bode A; Green JE
Transgenic Res; 2011 Apr; 20(2):247-59. PubMed ID: 20549348
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc.
Kundel DW; Stromquist E; Greene AL; Zhdankin O; Regal RR; Rose-Hellekant TA
Transgenic Res; 2012 Apr; 21(2):393-406. PubMed ID: 21863248
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Estrogen Receptor α in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor α-Positive Mammary Adenocarcinomas.
Furth PA; Wang W; Kang K; Rooney BL; Keegan G; Muralidaran V; Wong J; Shearer C; Zou X; Flaws JA
Am J Pathol; 2023 Jan; 193(1):103-120. PubMed ID: 36464513
[TBL] [Abstract][Full Text] [Related]
7. Mammary gland development and EDC-driven cancer susceptibility in mesenchymal ERα-knockout mice.
Wormsbaecher C; Cumbia BM; Amurgis EG; Poska JM; Price MR; Mo XM; Knoblaugh SE; Kurita T; Burd CJ
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37855322
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.
Andreani C; Bartolacci C; Wijnant K; Crinelli R; Bianchi M; Magnani M; Hysi A; Iezzi M; Amici A; Marchini C
Aging (Albany NY); 2017 Feb; 9(2):508-523. PubMed ID: 28238967
[TBL] [Abstract][Full Text] [Related]
9. Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses.
Jenkins EC; Chattopadhyay M; Gomez M; Torre D; Ma'ayan A; Torres-Martin M; Sia D; Germain D
Aging Cell; 2022 Oct; 21(10):e13665. PubMed ID: 36111352
[TBL] [Abstract][Full Text] [Related]
10. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.
Raho S; Capobianco L; Malivindi R; Vozza A; Piazzolla C; De Leonardis F; Gorgoglione R; Scarcia P; Pezzuto F; Agrimi G; Barile SN; Pisano I; Reshkin SJ; Greco MR; Cardone RA; Rago V; Li Y; Marobbio CMT; Sommergruber W; Riley CL; Lasorsa FM; Mills E; Vegliante MC; De Benedetto GE; Fratantonio D; Palmieri L; Dolce V; Fiermonte G
Nat Metab; 2020 Dec; 2(12):1373-1381. PubMed ID: 33230296
[TBL] [Abstract][Full Text] [Related]
11. Advances in Immunocompetent Mouse and Rat Models.
Bu W; Li Y
Cold Spring Harb Perspect Med; 2024 Mar; 14(3):. PubMed ID: 37217281
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-α signaling in post-natal mammary development and breast cancers.
Rusidzé M; Adlanmérini M; Chantalat E; Raymond-Letron I; Cayre S; Arnal JF; Deugnier MA; Lenfant F
Cell Mol Life Sci; 2021 Aug; 78(15):5681-5705. PubMed ID: 34156490
[TBL] [Abstract][Full Text] [Related]
13. Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing.
Liu C; Wu P; Zhang A; Mao X
Front Oncol; 2021; 11():593337. PubMed ID: 33842308
[TBL] [Abstract][Full Text] [Related]
14. Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo.
Bu W; Li Y
J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):389-396. PubMed ID: 33165800
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression.
Gelsomino L; Naimo GD; Malivindi R; Augimeri G; Panza S; Giordano C; Barone I; Bonofiglio D; Mauro L; Catalano S; Andò S
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32727138
[TBL] [Abstract][Full Text] [Related]
16. RAS as Supporting Actor in Breast Cancer.
Galiè M
Front Oncol; 2019; 9():1199. PubMed ID: 31781501
[TBL] [Abstract][Full Text] [Related]
17. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
Cornelissen LM; Henneman L; Drenth AP; Schut E; de Bruijn R; Klarenbeek S; Zwart W; Jonkers J
J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):305-321. PubMed ID: 31729597
[TBL] [Abstract][Full Text] [Related]
18. A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation.
Campbell KM; O'Leary KA; Rugowski DE; Mulligan WA; Barnell EK; Skidmore ZL; Krysiak K; Griffith M; Schuler LA; Griffith OL
Cell Rep; 2019 Aug; 28(6):1526-1537.e4. PubMed ID: 31390566
[TBL] [Abstract][Full Text] [Related]
19. Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: An Additional Mechanism in Cell-to-Cell Communication.
Giordano C; Gelsomino L; Barone I; Panza S; Augimeri G; Bonofiglio D; Rovito D; Naimo GD; Leggio A; Catalano S; Andò S
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31336913
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
